These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 10681285)

  • 1. Pathogenesis, natural history, treatment, and prevention of hepatitis C.
    Liang TJ; Rehermann B; Seeff LB; Hoofnagle JH
    Ann Intern Med; 2000 Feb; 132(4):296-305. PubMed ID: 10681285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis C.
    Satoor S; Raufman JP
    Clin Cornerstone; 2001; 3(6):37-46. PubMed ID: 11501193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic options for hepatitis C.
    Waters L; Nelson M
    Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for hepatitis C therapeutic intervention: now and next.
    Tan SL; He Y; Huang Y; Gale M
    Curr Opin Pharmacol; 2004 Oct; 4(5):465-70. PubMed ID: 15351350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C virus infection--after 20 years].
    Pár A
    Orv Hetil; 2010 Mar; 151(12):485-93. PubMed ID: 20231132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C: diagnosis and treatment.
    Wilkins T; Malcolm JK; Raina D; Schade RR
    Am Fam Physician; 2010 Jun; 81(11):1351-7. PubMed ID: 20521755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapies for chronic hepatitis C.
    Ferguson MC
    Pharmacotherapy; 2011 Jan; 31(1):92-111. PubMed ID: 21182362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV research and anti-HCV drug discovery: toward the next generation.
    Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C: natural history, diagnosis, and management.
    Lam NP
    Am J Health Syst Pharm; 1999 May; 56(10):961-73; quiz 974-5. PubMed ID: 10365720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection: the new global epidemic.
    Butt AA
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):241-9. PubMed ID: 15918781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
    Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS
    Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hepatitis C with peginterferon and ribavirin in Iceland from 2002-2012].
    Fridriksson B; Bergmann OM; Olafsson S
    Laeknabladid; 2017 Mars; 103(3):125-128. PubMed ID: 28262630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of hepatitis C].
    Moradpour D; Blum HE
    Praxis (Bern 1994); 2002 May; 91(22):977-82. PubMed ID: 12094432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.